Pasteurella multocida is a Gram-negative bacterial pathogen that is the causative agent of a wide range of diseases in many animal species, including humans. A widely used method for differentiation of P. multocida strains involves the Heddleston serotyping scheme. This scheme was developed in the early 1970s and classifies P. multocida strains into 16 somatic or lipopolysaccharide (LPS) serovars using an agar gel diffusion precipitin test. However, this gel diffusion assay is problematic, with difficulties reported in accuracy, reproducibility, and the sourcing of quality serovar-specific antisera. Using our knowledge of the genetics of LPS biosynthesis in P. multocida, we have developed a multiplex PCR (mPCR) that is able to differentiate strains based on the genetic organization of the LPS outer core biosynthesis loci. The accuracy of the LPS-mPCR was compared with classical Heddleston serotyping using LPS compositional data as the "gold standard." The LPS-mPCR correctly typed 57 of 58 isolates; Heddleston serotyping was able to correctly and unambiguously type only 20 of the 58 isolates. We conclude that our LPS-mPCR is a highly accurate LPS genotyping method that should replace the Heddleston serotyping scheme for the classification of P. multocida strains. P asteurella multocida is the primary causative agent of a wide range of economically important diseases, including hemorrhagic septicemia in ungulates, atrophic rhinitis in pigs, fowl cholera in birds, snuffles in rabbits, and enzootic pneumonia and shipping fever in cattle, sheep, and pigs (1). P. multocida also causes opportunistic infections in humans, often following cat or dog bites, and plays a contributory role, together with other pathogens, in a range of lower respiratory tract infections and sporadic septicemias in ungulates (1).
P
asteurella multocida is the primary causative agent of a wide range of economically important diseases, including hemorrhagic septicemia in ungulates, atrophic rhinitis in pigs, fowl cholera in birds, snuffles in rabbits, and enzootic pneumonia and shipping fever in cattle, sheep, and pigs (1) . P. multocida also causes opportunistic infections in humans, often following cat or dog bites, and plays a contributory role, together with other pathogens, in a range of lower respiratory tract infections and sporadic septicemias in ungulates (1) .
P. multocida strains have classically been differentiated using serological techniques. Strains can be classified into five capsular serogroups (A, B, D, E, and F) using an indirect hemagglutination test (2) and into 16 somatic or lipopolysaccharide (LPS) serovars (serotypes) using the Heddleston gel diffusion precipitin test (3) . Both of these schemes have been widely used. Isolates are commonly assigned a combined designation, such as A:1 (capsular serogroup A and LPS serovar 1) or B:2 (capsular serogroup B and LPS serovar 2).
P. multocida LPS is an immunodominant antigen critical for homologous protection stimulated by bacterin (killed-cell) vaccines (4) . Furthermore, in the P. multocida strain VP161, a fulllength LPS molecule is essential for the ability to cause acute disease (5, 6 ). Heddleston serotyping is currently the only method used to differentiate P. multocida strains on the basis of LPS type. However, the accuracy of Heddleston serotyping has never been objectively tested, as the precise LPS structures produced by different strains have not been known. Indeed, there have been many informal as well as formal reports that the Heddleston system fails to type many isolates and lacks accuracy and reproducibility (7, 8) . Furthermore, Heddleston serotyping is time-consuming and requires access to good-quality, serovar-specific antisera.
We have recently carried out a comprehensive analysis of the LPS structures expressed by the 16 Heddleston type strains and identified the genes required for LPS assembly in each strain (9) (10) (11) (12) (13) (14) (15) (16) . These combined analyses showed that the LPS produced by all strains consisted of a highly conserved inner core and a variable outer core and revealed that each of the 16 Heddleston type strains expresses structurally distinct LPS. Importantly, these analyses also showed that only eight unique LPS outer core biosynthesis loci are found in the 16 Heddleston type strains ( Fig. 1) . We have designated these genetic loci L1 through to L8. The type strains of Heddleston serovars 1, 2, 3, 5, 6, 8, 9, 12, and 16 express full-length or "parent" LPS structures, and the type strains of Heddleston serovars 4, 7, 10, 11, 13, 14, and 15 express truncated LPS-the result of mutations within the LPS outer core biosynthesis loci. The partial differentiation of P. multocida strains on the basis of LPS biosynthesis genes has been reported previously (17) . Using PCR-restriction fragment length polymorphism (RFLP) analysis, P. multocida strains were grouped into 5 PCR-RFLP types. However, only 11 of the 16 Heddleston serovars were included in the study. Here we report the development and testing of a multiplex PCR (mPCR) using the full set of Heddleston serovar type strains, which can accurately differentiate P. multocida strains into one of the eight distinct LPS genotypes. By comparing the results of Heddleston serotyping and the LPS-mPCR to the LPS structures predicted from LPS compositional analysis by mass spectrometry (MS), we have determined the accuracy of this mPCR and Heddleston serotyping for predicting LPS type. The LPSmPCR gave a result that was indicative of LPS genotype Ͼ98% of the time, and we propose that the LPS-mPCR assay should be used to differentiate strains into their appropriate LPS genotype and, together with the cap mPCR, form a new molecularly based typing system for accurate strain differentiation of P. multocida.
MATERIALS AND METHODS
Strains used. All P. multocida strains were grown at 37°C in heart infusion (HI) (Oxoid, Basingstoke, United Kingdom) liquid broth with shaking or on solid HI medium containing 1.5% agar. The P. multocida strains used in the study are described in Table 1 . All field isolates were confirmed as P. multocida by use of one of two P. multocida-specific PCR assays (18, 19) .
Serotyping. Each isolate of P. multocida was serotyped via the Heddleston method as described previously (3) .
Molecular biology techniques. Genomic DNA was purified from 1 ml of P. multocida overnight culture using the RBC genomic DNA purification kit (RBC, Taiwan). Each of the final LPS-mPCRs (50-l final volume) was performed in 1ϫ Taq polymerase buffer (10 mM Tris-HCl, 1.5 mM MgCl 2 , 50 mM KCl [Roche Diagnostic GmbH, Mannheim, Germany]) containing 0.4 M each primer (Table 2) , 0.2 mM deoxynucleoside triphosphates (dNTPs), and 1.7 U Taq polymerase (Roche Diagnostic GmbH, Mannheim, Germany). For each colony PCR, material from 2 to 3 well-isolated P. multocida colonies (obtained from overnight growth of each isolate at 37°C on an HI-1.5% agar plate) was collected using a sterile tip on a 20-l micropipette (volume set at 20 l) inserted into the middle of each colony. The collected material was then added to a 50-l PCR mixture and mixed thoroughly by pipetting. For PCR using genomic DNA, approximately 50 ng of column-purified DNA was added to each PCR mixture. All reaction mixtures were mixed briefly then centrifuged (10 s, 13,000 ϫ g). All PCRs were performed in an Eppendorf Mastercycler. For colony PCR, the cycling conditions were 96°C for 10 min, followed by 30 cycles of 96°C for 30 s, 52°C for 30 s, and 72°C for 2.5 min, with a final extension at 72°C for 5 min. For PCR using genomic DNA as the template, the cycling conditions were identical to those in the colony PCR, except that the initial denaturation step at 96°C was reduced to 5 min. The PCR products generated from the LPS-mPCR were analyzed by gel electrophoresis using 2% agarose-Tris-acetate-EDTA (TAE) gel in 1ϫ TAE buffer for 90 min at constant voltage (70 V).
For the initial LPS-mPCR (LPS-mPCR version 1 [LPS-mPCRv1]), all primers were used at a concentration of 0.3 M, except for the L6 primers, which were used at 0.5 M. The cycling conditions for the LPS-mPCRv1 using bacterial colony material as the template were 95°C for 10 min, followed by 30 cycles of 95°C for 30 s, 54°C for 30 s, and 72°C for 2.5 min, with a final extension at 72°C for 2 min.
Nucleotide sequences were determined by direct sequencing from genomic DNA and/or by sequencing of amplified PCR fragments as described previously (10) . Sequencing reactions were analyzed using the Applied Biosystems 3730S genetic analyzer, and sequencing chromatograms were analyzed and the LPS loci assembled using Vector NTI Advance 11 (Invitrogen). Bioinformatic analyses, including amino acid sequence alignments, were conducted using BLAST and ClustalW2.
LPS sugar compositional analyses. For compositional analysis of LPS produced by the Australian field isolates, small quantities of LPS were isolated from plate-grown cells as described previously (20) . O-deacylated LPS (LPS-OH), core oligosaccharide (OS), and completely deacylated LPS were all isolated and purified from LPS as described previously (21) . The sugar composition of the LPS from selected strains was determined by mass spectrometry as previously described (22) . The predicted LPS structures produced by the P. multocida isolates were determined using MS compositional analysis and comparison with the known compositions and structures of the 16 Heddleston serovar type strains (9) (10) (11) (12) (13) (14) (15) (16) .
RESULTS
Design of a first-generation mPCR capable of differentiating P. multocida strains based on the genetics of LPS biosynthesis. We have shown previously that the 16 unique LPS outer core structures produced by the P. multocida Heddleston type strains are PM993  H8  2002  Duck  PM995  H3  2002  Chicken  PM1075  H16  2004  Chicken  PM1098  H15  2004  Unknown  PM1099  H10  2004  Unknown  PM1103  H10  2004  Unknown  PM1113  NT  2004  Avian  PM1120  NT  2005  Chicken  PM1124  H1, H4, H12  2005  Unknown  PM1128  H10  2005  Bovine  PM1132  H1, H3, H4, H10, H14  2005  Pig  PM1153  H1, H3, H7  2005  Avian  PM1165  H1  2006  Duck  PM1193  H3  2006  Duck  PM1205  H1  2007  Emu  PM1258  NT  2010  Chicken  PM1268  NT  2010  Chicken  PM1300  H4  2009  Turkey  PM1304  H1  2009  Chicken  PM1315  H1  2009  Chicken  PM1316  H4  2009  Unknown  PM1317  H3  2009  Unknown  PM1320  H10, H13, H14  2010  Chicken  PM1369  H1  2010  Chicken  PM1396 H1, H3 2010 Unknown generated from only eight distinct genetic loci, which we have named L1 to L8 ( Fig. 1 ) (9) (10) (11) (12) (13) (14) (15) 20) . We have therefore designated the following Heddleston serovar type strains as the LPS genotype type strains: X73 (L1), P1702 (L2), P1059 (L3), P2192 (L4), P2095 (L5), P1573 (L6), P1581 (L7), and P2723 (L8). Within each LPS genotype, strains displaying variation and/or truncation of the LPS structure can arise from random point mutations or deletions, in almost all cases, within the LPS outer core biosynthesis genes. These mutations can result in a change of function (sugar or donor specificity) or a total loss of function resulting in early termination of LPS assembly (10, 11) . Given the random nature of LPS mutations, it was concluded that designing a PCR specific for each precise LPS structure identified was not possible. Thus, an mPCR assay was designed that was capable of differentiating the eight different LPS genotypes. In all of the P. multocida strains so far examined, the genes required for synthesis of the LPS outer core are located between the conserved non-LPS genes priA and fpg (23) . Each LPS outer core biosynthesis locus contains between 5 and 13 genes, including the highly conserved rpL31_2 gene, encoding ribosomal protein L31, which is not involved in LPS assembly (Fig. 1) . To design an mPCR specific for the LPS outer core biosynthesis loci, a bioinformatic comparison was first performed using all the predicted protein sequences from each of the eight LPS outer core biosynthesis loci. One unique (or least similar) protein sequence was selected, and the corresponding nucleotide sequence was compared with the entire nucleotide sequence of each of the eight LPS loci. Where some similarity was observed in the selected region with the nucleotide sequence from another locus, nucleotide alignments were generated and the alignments visually inspected to identify the most divergent DNA sections. This information was used to design a set of eight primer pairs specific for each of the eight LPS biosynthetic loci (Table 2) . Each primer pair was also designed to generate a distinct amplicon size for optimal electrophoretic separation on 2% agarose gels.
Testing of the LPS-mPCRv1. All primer sets were initially tested in separate PCRs using either genomic DNA or colonyderived cells from each of the Heddleston type strains as the template. All PCRs amplified a product of the correct size when the appropriate type strains were used as the template (e.g., when the L1 primers were used against the L1 strains X73 and P2225). The different primer pairs were then combined and used in a single mPCR using either genomic DNA or colony-derived cells from each of the Heddleston type strains as the template. Following PCR optimization, a reproducible mPCR (LPS-mPCR version 1 [LPS-mPCRv1]) was developed that generated a single product of the expected size for all strains (Fig. 2A) .
Testing of the LPS-mPCRv1 against Australian P. multocida field isolates. To test the reproducibility and accuracy of LPSmPCRv1, 58 P. multocida field isolates were typed using both LPSmPCRv1 and classical Heddleston serotyping. The 58 field isolates included strains obtained from a range of Australian poultry farms and other sources between 1977 and 2011. In total, 33 of the strains were recorded as being isolated from chickens, 8 from turkeys, 4 from ducks, and 1 from an emu. The host species was not recorded for 10 of the isolates. One bovine isolate and one porcine isolate were also included (Table 1) .
Historical strains were serologically typed using the Heddleston serotyping system when they were first received at the Australian reference laboratory (Agri-Science Queensland), and the typing was then repeated again for this study. For some strains, the serovar determined when the Heddleston serotyping was re- peated was not in agreement with the initial serovar typing result (Table 1) . Of the 58 strains, 32 gave an unambiguous Heddleston serovar result (55%) ( Table 1) , 17 gave an ambiguous result of two or more possible serovars, and 9 were nontypeable (no precipitin line observed). The most common serovars identified unambiguously were serovars 1 and 3. All strains were then LPS genotyped using the LPS-mPCRv1. An example of an LPS-mPCRv1 result is shown in Fig. 2B . Of the 58 strains tested, the LPS-mPCRv1 gave an unambiguous LPS genotype for 48 of the strains (Table 3) , but no PCR product could be generated for 10 strains (nontypeable). A comparison of the LPS-mPCRv1 genotype and Heddleston serovar designations of each strain (Table 3) revealed that there was complete agreement between the typing methods for only 16 of the 58 strains. Partial agreement was obtained for a further 11 strains (where serotyping gave an ambiguous result and the LPS-mPCRv1 result was in agreement with one of the serotyping results). For 15 strains, the LPS-mPCRv1 gave a locus designation that was incompatible with the serovar designation (Table 3 ). These data indicate that there were clear discrepancies between Heddleston serotyping and LPS genotype, as determined by the LPS-mPCRv1. Importantly, the LPS-mPCRv1 consistently assigned strains to a single genotype, whereas serotyping frequently assigned strains to multiple Heddleston serovars.
In order to determine whether Heddleston serotyping or the LPS-mPCRv1 gave a more accurate representation of the LPS produced by each strain, the LPS composition from a set of selected strains was analyzed by mass spectrometry. The strains examined included five strains from the agreement group, all strains from the nonagreement group, 9 of the 11 strains from the partial agreement group (where Heddleston serotyping gave ambiguous results), and all strains that remained nontypeable in one or both typing systems. As we have reported previously, these analyses identified a number of strains belonging to the L3 genotype, which expressed multiple LPS glycoforms (10) . When interpreting the typing results, the LPS glycoform that contained the largest number of sugars/residues was deemed to be representative of the most extended LPS structure produced by the strain, and any additional glycoforms observed that contained fewer sugars (but common to the largest glycoform) were considered truncated variants.
As expected, the five strains analyzed within the agreement group (Table 3) gave LPS-mPCRv1 designations that were in agreement with both LPS composition and with serotyping. The LPS composition of the nine strains examined within the partial agreement group correlated always with the genotype designation but correlated with one of the multiple Heddleston serovar designations in only 6 of the 9 strains (Table 3 ). The LPS composition of two strains in the agreement group (PM120 and PM1193) and two in the partial agreement group (PM3 and PM51) did not correlate precisely with the serovar-specific LPS structures within the assigned LPS genotype. However, in each case the LPS composition did correlate with a truncated version of the LPS structure specific to the assigned LPS genotype (10, 11) . For the strains where serotyping and PCR were in nonagreement, the LPS compositional analysis was always compatible with the LPS genotype assigned using the LPS-mPCRv1. In contrast, the Heddleston serotyping designation did not correlate with the predicted LPS composition for any strain in this group, clearly showing that Heddleston serotyping is unreliable for prediction of LPS composition. Importantly, the LPS-mPCRv1 gave unambiguous LPS genotyping results (producing only a single amplicon) that always correlated with LPS composition (Table 3) .
Redesign of the LPS-mPCR to increase coverage. The LPSmPCRv1 gave an unambiguous LPS genotype for 48 of 58 field strains (Table 3 ) but failed to amplify a product from 10 isolates. PCR and nucleotide sequence analyses of the LPS outer core biosynthesis locus in each strain revealed that nine of the untypeable strains contained an L3 LPS locus but with significant nucleotide differences within gatG, where the L3 primers were located. The tenth strain, PM135, contained an L7 LPS locus but with a major deletion of 2,210 nucleotides (14) that included ppgB, where the L7 primers for the LPS-mPCRv1 were located.
To improve the strain coverage of the LPS-mPCRv1, the nucleotide sequence of the L3 type strain (P1059) was used to design new primers in a region within gatF that shared 100% identity with the nine L3 strains that were nontypeable using the LPSmPCRv1 (Fig. 1) . Substitution of the gatF L3 primers in the multiplex PCR resulted in amplification of all locus-specific products from the appropriate templates, except for locus 6, where only weak amplification of the product was observed for some strains (data not shown). To improve the L6 amplicon yield, the L6 primers were slightly modified. This final typing PCR was designated the LPS-mPCR. The full set of the final LPS-mPCR primers and amplicon sizes is shown in Table 2 .
The final LPS-mPCR was used to genotype the 16 Heddleston type strains and was able to accurately differentiate all of these strains into the eight LPS genotypes (Fig. 3) . The LPS-mPCR was then used to genotype the 58 field isolates. This final LPS-mPCR gave a single reproducible amplification product for 57 of 58 strains (strain PM135 was nontypeable), including the nine L3 strains that were nontypeable using the LPS-mPCRv1 (data not shown). All positive LPS-mPCR results were compatible with the LPS compositions that were determined (Table 3) .
DISCUSSION
In this study, a multiplex PCR was designed to differentiate P. multocida strains on the basis of the LPS genotype. The final LPSmPCR was able to unambiguously type the 16 Heddleston type strains and 57 of the 58 field isolates. However, strain PM135 remained untypeable, due to a large deletion in the region where the L7 LPS-mPCR primers were located (14) . The failure of the LPS-mPCR due to large deletions within the LPS loci where primers are located cannot be avoided. However, our previous analyses of the Heddleston type strains and field isolates containing LPS gene mutations indicate that such large deletions are rare; most mutations within the P. multocida LPS outer core biosynthesis loci involve single point mutations (9) (10) (11) and would be unlikely to compromise PCR amplification.
During the testing of the LPS-mPCR for differentiation of P. multocida isolates, mass spectrometry analysis was used as the "gold standard" to assess the composition of the LPS produced by individual strains. This method of LPS analysis identifies sugar type and overall sugar content, which are then compared to the LPS compositions of the fully elucidated Heddleston LPS structures to predict the LPS glycoforms expressed by any particular strain. Our previous analyses of the LPS genetics and structure in P. multocida showed that strains with the same serological designation can produce structurally distinct LPS (9-16). These analyses also showed that the LPS structures produced by many P. multocida strains are truncated variants of the full-length or "parent" LPS structure and that there is significantly more LPS diversity in the field than is represented by the current 16 type strains (9) (10) (11) (12) 14) . Interestingly, many P. multocida field isolates belonging to the L3, L4, and L6 genotypes produce a wide range of LPS glycoforms, including some which have a significantly truncated LPS outer core or no outer core at all. Many of these strains were isolated from poultry exhibiting clear signs of fowl cholera (data not shown), indicating that strains belonging to these genotypes do not require a full-length LPS molecule to cause disease. Our studies on the L1/serovar 1 strain VP161 have shown that any shortening of the LPS outer core structure in this strain results in attenuation of virulence in chickens (24) , but it is possible that isolates expressing truncated LPS may be able to persist in some host niches but are not as virulent as parent strains expressing fulllength LPS. Indeed, infection of chickens with a VP161 hptE LPS mutant (which produces a highly truncated outer core) showed that this mutant could persist at the site of muscle injection but could not be recovered from the blood, thus supporting this hypothesis (20) . Importantly, many of the structures expressed by L3 and L6 genotype strains mimic host glycosphingolipids, and this may allow the bacteria to avoid recognition by the components of the innate immune system (10, 11) .
Our comparison of LPS composition, Heddleston serotyping, and LPS-mPCR typing showed clearly that the Heddleston serovar designation frequently failed to correlate with the composition of the LPS produced by each strain. In contrast, the LPS-mPCR assay, specific for the identification of the LPS outer core biosynthesis loci, always correlated with LPS composition. Knowledge of the LPS genotype allows for the identification of the LPS type and possible range of LPS structures that strains can produce. However, the LPS-mPCR cannot predict the precise LPS structures produced by individual strains as random mutations within the LPS locus often lead to changes in LPS structure. We propose that the high diversity in numbers and types of LPS molecules produced by P. multocida strains indicates that a typing system exactly predictive of LPS structure is not feasible. If knowledge of the precise LPS structure is important for diagnosis and the control of outbreaks, then following mPCR analysis, further experiments would need to be conducted, such as carbohydrate-specific silver staining of cell lysates to assess the relative size of the LPS produced. Alternatively, for more detailed analysis, nucleotide sequencing of the LPS biosynthesis locus to identify the specific LPS gene mutations combined with carbohydrate mass spectrometry could be employed. However, these detailed analyses are beyond the scope of diagnostic laboratories.
The LPS-mPCR developed here is a highly reproducible typing system for differentiating P. multocida strains. We have also shown that many field isolates produce multiple LPS glycoforms simultaneously; these naturally occurring "multivalent" strains could be excellent candidates for killed-cell vaccines as they may show broader protective efficacy than strains expressing single LPS molecules. We are currently assessing this possibility.
